High level HIV-1 DNA concentrations in brain tissues differentiate patients with post-HAART AIDS dementia complex or cardiovascular disease from those with AIDS

Science in China, Series C: Life Sciences

Volumn 52, Issue 7, 2009, Pages 651-656

  Zhao, Li ^a   Galligan, Derek C ^b   Lamers, Susanna L ^c   Yu, Stephanie ^d   Shagrun, Lamia ^b   Salemi, Marco ^e   McGrath, Michael S ^b  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Gene Johnson Inc   (United States)

^d Pathologica LLC   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

AIDS dementia complex; Cardiovascular disease; Cerebrovascular atherosclerosis; DNA; HIV 1; Quantitative PCR

Indexed keywords

VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; AUTOPSY; BASAL GANGLION; BRAIN; CARDIOVASCULAR DISEASE; DIFFERENTIAL DIAGNOSIS; FEMALE; GENETICS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOLATION AND PURIFICATION; MALE; MENINX; MIDDLE AGED; MORTALITY; PATHOLOGY; SPINAL CORD; VIROLOGY; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS DEMENTIA COMPLEX; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; AUTOPSY; BASAL GANGLIA; BRAIN; CARDIOVASCULAR DISEASES; DIAGNOSIS, DIFFERENTIAL; DNA, VIRAL; FEMALE; HIV-1; HUMANS; MALE; MENINGES; MIDDLE AGED; SPINAL CORD; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 70350056625     PISSN: 10069305     EISSN: 18622798     Source Type: Journal    
DOI: 10.1007/s11427-009-0085-5     Document Type: Article

References (35)

1. Gonzalez-Scarano F, Martin-Garcia J. The neuropathogenesis of AIDS. Nat Rev Immunol, 2005, 5: 69-81.
2. Sacktor N. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol, 2002, 8(suppl 2): 115-121.
3. Sacktor N, Lyles R H, Skolasky R, et al. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology, 2001, 56: 257-260.
4. Sacktor N, Tarwater P M, Skolasky R L, et al. CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing. Neurology, 2001, 57: 542-544.
5. Palella F J Jr, Baker R K, Moorman A C, et al. Mortality in the highly active antiretroviral therapy era changing cause of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr, 2006, 43: 27-34.
6. Bozzette S A, Ake C F, Tam H K, et al. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med, 2003, 348: 702-710.
7. Friis-Mi{dotless}ller N, Sabin C A, Weber R, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med, 2003, 349: 1993-2003.
8. Holmberg S D, Moorman A C, Williamson J M, et al. Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet, 2002, 360: 1747-1748.
9. Mooser V. Atherosclerosis and HIV in the highly active antiretroviral therapy era: toward an epidemic of cardiovasvular disease? AIDS, 2003, 17(suppl 1): s65-s69.
10. Sudano I, Spieker L E, Noll G, et al. Cardiovascular disease in HIV infection. Am Heart J, 2006, 151: 1147-1155.
11. Stein J H, Klein M A, Bellehumeur J L, et al. Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation, 2001, 104: 257-262.
12. Monier P, McKown K, Bronze M S. Osteonecrosis complicating highly active antiretroviral therapy in patients infected with human immunodeficiency virus. Clin Infect Dis, 2000, 31: 1488-1492.
13. Meng Q, Lima J A, Lai H, et al. Coronary artery calcification, atherogenic lipid changes, and increased erythrocyte volume in black injection drug users infected with human immunodeficiency virus-1 treated with protease inhibitors. Am Heart J, 2002 144: 642-648.
14. Hsue P Y, Lo J C, Franklin A, et al. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation, 2004, 109: 1603-1608.
15. Shah S S, Zimmerman R A, Rorke L B, et al. Cerebrovascular complications of HIV in children. Am J Neuroradiol, 1996, 17: 1913-1917.
16. An S F, Groves M, Giometto B, et al. Detection and localisation of HIV-1 DNA and RNA in fixed adults AIDS brain by polymerase chain reaction/in situ hybridisation technique. Acta Neuropathol, 1999, 98: 481-487.
17. Bell J E, Brettle R P, Chiswick A, et al. HIV encepholitis, proviral load and dementia in drug users and homosexuals with AIDS Effect of neocortical involvement. Brain, 1998, 121(Pt11): 2043-2052.
18. Glass J D, Fedor H, Wesselingh S L, et al. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol, 1995, 38: 755-762.
19. Johnson R T, Glass J D, McArthur J C, et al. Quantitation of Human Immunodeficiency Virus in Brains of Demented and Nondemented Patients with Acquired Immunodeficiency Syndrome. Ann Neurol, 1996, 39: 392-395.
20. van Marle G, Power C. Human immunodeficiency virus type 1 genetic diversity in the nervous system: Evolutionary epiphenomenon or disease determinant? J Neurovirol, 2005, 11: 107-128.
21. Ohagen A, Devitt A, Kunstman K J, et al. Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS. J Virol, 2003, 77: 12336-12345.
22. Wiley C A, Achim C L, Chritopherson C, et al. HIV mediates a productive infection of the brain. AIDS, 1999, 13: 2055-2059.
23. Paton P, Poly H, Gonnaud P M, et al. Acute meningoradiculitis concomitant with seroconversion to human immunodeficiency virus type 1. Res Virol, 1990, 141: 427-433.
24. Salemi M, Lamers S L, Yu S, et al. Phylodynamic analysis of human immunodeficiency virus type 1 in distinct brain compartments provides a model for the neuropathogenesis of AIDS. J Virol, 2005, 79: 11343-11352.
25. Hansson G K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med, 2005, 352: 1685-1695.
26. Linton M F, Fazio S. Macrophages, inflammation, and atherosclerosis. International Journal of Obesity, 2003, 27Suppl 3: s35-s40.
27. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol, 1995, 57: 791-804.
28. Williams K C, Hickey W F. Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu Rev Neurosci, 2002, 25: 537-562.
29. Barbaro G. Cardiovascular manifestations of HIV Infection. Circulation, 2002, 106: 1420-1425.
30. Barbaro G, Fisher S D, Lipshultz S E. Pathogenesis of HIV-associated cardiovascular complications. Lancet Infect Dis, 2001, 1: 115-124.
31. Currier J S, Taylor A, Boyd F, et al. Coronary heart disease in HIV-infected individuals. J Acquir Immune Defic Syndr, 2003, 33: 506-512.
32. Magen E, Elbirt D, Sthoeger Z. Cardiovascular disease prevention and treatment in patients with human immunodeficiency virus. Isr Med Assoc J, 2005, 7: 252-256.
33. An S F, Giometto B, Scaravilli F. HIV-1 DNA in brain in AIDS and pre-AIDS: correlation with the stage of disease. Ann Neurol, 1996, 40: 611-617.
34. Bockstahler L E, Werner T, Festl H, et al. Distribution of HIV genomic DNA in brain of AIDS patients. Clin Diagn Virol, 1995, 3: 61-72.
35. Williams K C, Corey S, Westmoreland SV, et al. Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: Implications for the neuropathogenesis of AIDS. J Exp Med, 2001, 193: 905-915.